The first pill to help in the fight against Covid-19 could be made available within months, but Australia hasn’t signed on to purchase any doses just yet.
Interim clinical trial results of the experimental antiviral treatment molnupiravir have shown the drug cut the chance of patients being hospitalised by 50 per cent and dramatically reduced the risk of death.
US manufacturers Merck said it would apply to the Food and Drug Administration for an emergency use authorisation for the drug within the next fortnight.
Interim clinical trial results of the experimental antiviral treatment molnupiravir have shown the drug cut the chance of patients being hospitalised by 50 per cent and dramatically reduced the risk of death.
US manufacturers Merck said it would apply to the Food and Drug Administration for an emergency use authorisation for the drug within the next fortnight.
Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey.
Comment